相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
Frederick J. Raal et al.
LANCET (2010)
Other Therapies for Reducing Low-Density Lipoprotein Cholesterol: Medications in Development
Evan A. Stein
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2009)
Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice
Esther Merki et al.
CIRCULATION (2008)
Detection of apolipoproteins B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases
Takamitsu Nakano et al.
CLINICA CHIMICA ACTA (2008)
Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies
G. N. Fredrikson et al.
JOURNAL OF INTERNAL MEDICINE (2008)
Subendothelial lipoprotein retention as the initiating process in atherosclerosis -: Update and therapeutic implications
Ira Tabas et al.
CIRCULATION (2007)
Retention of low-density lipoprotein in atherosclerotic lesions of the mouse -: Evidence for a role of lipoprotein lipase
Maria Gustafsson et al.
CIRCULATION RESEARCH (2007)
ISIS 301012 gene therapy for hypercholesterolemia: Sense, antisense, or nonsense?
Matthew K. Ito
ANNALS OF PHARMACOTHERAPY (2007)
A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome
Karsten Hartvigsen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Aberrant hepatic expression of PPARγ2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis
Yuan-Li Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A systematic review of LDL apheresis in the treatment of cardiovascular disease
Jeff Thompsen et al.
ATHEROSCLEROSIS (2006)
Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B
John J. P. Kastelein et al.
CIRCULATION (2006)
Intestinal cholesterol absorption is substantially reduced in mice deficient in both ABCA1 and ACAT2
RE Temel et al.
JOURNAL OF LIPID RESEARCH (2005)
Apolipoprotein B:: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis
SO Olofsson et al.
JOURNAL OF INTERNAL MEDICINE (2005)
Modulation of atherosclerosis in mice by Toll-like receptor 2
AE Mullick et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis
RM Crooke et al.
JOURNAL OF LIPID RESEARCH (2005)
Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption
JJ Repa et al.
JOURNAL OF LIPID RESEARCH (2005)
Genetic basis of atherosclerosis: Part I - new genes and pathways
AJ Lusis et al.
CIRCULATION (2004)
Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines
SM Grundy et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Molecular mediators of hepatic steatosis and liver injury
JD Browning et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis
MF Khalil et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Minireview: The AMP-activated protein kinase cascade: The key sensor of cellular energy status
DG Hardie
ENDOCRINOLOGY (2003)
Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass
O Gavrilova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene
GG Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor γ1 (PPARγ1) overexpression
ST Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
JD Horton et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice
HR Davis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
分享论文
